We recently sent a letter to heads of services accredited by our Society with general information about the Anais Brasileiros de Dermatologia (ABD), the new section on infectious/parasitic diseases and our efforts to increase the impact factor, promote higher visibility and better classification among the main international dermatologic journals. Currently, we occupy the 54th position among the 62 dermatology journals indexed worldwide. We are ahead of Annales de Dermatologie et de Vénéréologie, and Leprosy Review. We can improve with the collaboration of all. We are among the three largest dermatology societies in the world.
We would like to thank all colleagues that participated with responses and suggestions.
Among the correspondences sent to the heads of dermatology services, Dr. Jaison Barreto, expressed concerns and critiques regarding the performance of the editors and the quality of the articles published, especially on Hansen’s disease, the article of Continuing Medical Education in particular.1
Dr. Laila de Laguiche, in another correspondence, criticizes the Editorial of the same journal number. In that Editorial, attention is drawn to the CME article and possibilities of changes in the therapeutic scheme for Hansen’s disease.
In this number of the ABD, we transcribed the texts sent by Dr. Jaison Barreto and Dr. Laila de Laguiche, and the reply of the authors of the CME article.
We believe the reply of the CME article’s authors are enough to explain the Editorial’s reasons and we will let our colleagues who work with Hansen’s disease be the judges of the quality of the articles published in our journal.
